These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1493390)

  • 41. Factors relevant to preventing embolic stroke in patients with non-rheumatic atrial fibrillation.
    Flegel KM; Hutchinson TA; Groome PA; Tousignant P
    J Clin Epidemiol; 1991; 44(6):551-60. PubMed ID: 2037860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticoagulation for atrial fibrillation and stroke prevention.
    Boysen G
    Neuroepidemiology; 1993; 12(5):280-4. PubMed ID: 8309503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the cost-effectiveness of new oral anticoagulants for the prevention of stroke and systemic embolism in atrial fibrillation in a UK setting.
    Zheng Y; Sorensen SV; Gonschior AK; Noack H; Heinrich-Nols J; Sunderland T; Kansal AR
    Clin Ther; 2014 Dec; 36(12):2015-2028.e2. PubMed ID: 25438722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentre F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Cerebrovasc Dis; 2001; 12(3):245-52. PubMed ID: 11641591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness Analysis Comparing Apixaban and Acenocoumarol in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation in Spain.
    Barón Esquivias G; Escolar Albaladejo G; Zamorano JL; Betegón Nicolás L; Canal Fontcuberta C; de Salas-Cansado M; Rubio-Rodríguez D; Rubio-Terrés C
    Rev Esp Cardiol (Engl Ed); 2015 Aug; 68(8):680-90. PubMed ID: 25498373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
    Koudstaal PJ
    Cochrane Database Syst Rev; 2000; (2):CD000187. PubMed ID: 10796315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269].
    Mant JW; Richards SH; Hobbs FD; Fitzmaurice D; Lip GY; Murray E; Banting M; Fletcher K; Rahman J; Allan T; Raftery J; Bryan S;
    BMC Cardiovasc Disord; 2003 Aug; 3():9. PubMed ID: 12939169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Costs of coronary heart disease and stroke: the case of Sweden.
    Zethraeus N; Molin T; Henriksson P; Jönsson B
    J Intern Med; 1999 Aug; 246(2):151-9. PubMed ID: 10447784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke.
    Mitropoulou C; Fragoulakis V; Bozina N; Vozikis A; Supe S; Bozina T; Poljakovic Z; van Schaik RH; Patrinos GP
    Pharmacogenomics; 2015 Jan; 16(2):137-48. PubMed ID: 25616100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Common flaws exist in published cost-effectiveness models of pharmacologic stroke prevention in atrial fibrillation.
    Limone BL; Baker WL; Mearns ES; White CM; Kluger J; Coleman CI
    J Clin Epidemiol; 2014 Oct; 67(10):1093-102. PubMed ID: 25018102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atrial fibrillation, stroke, and antithrombotic treatment.
    Cheng TO
    Am Heart J; 1994 Apr; 127(4 Pt 1):961-8. PubMed ID: 8154448
    [No Abstract]   [Full Text] [Related]  

  • 53. Cost-Effectiveness of High-Dose Edoxaban Compared with Adjusted-Dose Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation Patients.
    Nguyen E; Egri F; Mearns ES; White CM; Coleman CI
    Pharmacotherapy; 2016 May; 36(5):488-95. PubMed ID: 27015873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives.
    Blann AD; Boriani G; Lip GY
    Europace; 2016 Oct; 18(10):1507-1513. PubMed ID: 27876695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients.
    Shah A; Shewale A; Hayes CJ; Martin BC
    Stroke; 2016 Jun; 47(6):1555-61. PubMed ID: 27103018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [European atrial fibrillation trial (EAFT). Secondary prevention with anticoagulants and aspirin in patients with non-valvular atrial fibrillation having suffered a transient ischemic attack or a regressive vascular accident].
    Besson G; Bogousslavsky J
    Rev Med Suisse Romande; 1991 Jan; 111(1):49-55. PubMed ID: 2006364
    [No Abstract]   [Full Text] [Related]  

  • 57. Anticoagulation to prevent stroke in atrial fibrillation and its implications for managed care.
    Singer DE
    Am J Cardiol; 1998 Mar; 81(5A):35C-40C. PubMed ID: 9525571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Circulation; 2012 May; 125(19):2298-307. PubMed ID: 22514252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.
    Reddy P; Giugliano RP
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):526-32. PubMed ID: 24659084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
    Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.